Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
September 2014

Inhaled Loxapine
An inhalation powder formulation of loxapine (Adasuve) has been approved by the FDA to treat acute agitation resulting from schizophrenia or bipolar I disorder in adults.

Lithium in the Elderly
Elderly patients taking low doses of lithium to attenuate the course of Alzheimer disease experience more overall adverse effects than placebo-treated patients, most notably weight gain, diabetes mellitus, and cardiac arrhythmia.

Antipsychotic-Induced Weight Gain and Other Adverse Metabolic Effects: Purported Antidotes
When switching agents is not feasible and diet and exercise are ineffective, current evidence points to metformin (Glucophage and others) as the best antidote for antipsychotic-induced weight gain.

In Brief
Venlafaxine Recall Due to Dissolution Failure; Interventions to Reduce Smoking Are Associated with Decreases in Suicide Risk

SSRIs and QT Prolongation
A recent meta-analysis found varying degrees of QT interval prolongation among selective serotonin reuptake inhibitors (SSRIs).

Download a Sample Issue of BTP

A following sample issue of Biological Therapies in Psychiatry is available in .pdf format. These files require Adobe Acrobat© Reader to view. (If you do not currently have the Acrobat Reader, click here to download).

Download a free sample pdf of BTP



One, two and three-year subscriptions are immediately available. Each subscription allows you full online access to current and recent issues, a searchable online database, downloadable audio files, and a printed newsletter that will be mailed to you monthly. You'll receive timely, accurate information at a very reasonable price. A one-year US subscription is only $86.00.


Subscribe